We use cookies to make your experience better. To comply with the new e-Privacy directive, we need to ask for your consent to set the cookies. Learn more.
Conatumumab (AMG-655)
AMG 655
TRAIL-R2 mAb
Human Anti-TNFRSF10B Recombinant Antibody
TRAIL-R2 mAb
Human Anti-TNFRSF10B Recombinant Antibody
As low as
€600.00
In stock
Ref
00124840
Conatumumab (AMG 655) is a human monoclonal agonist antibody against human death receptor 5 (DR5, TRAILR2) (Kd: 1 nM for the long form of DR5, 0.8 nM for the short form of DR5). Conatumumab induces apoptosis via caspase activation. Conatumumab can be used in the research of cancers. .
| ID Covalab | mab0348-p |
|---|---|
| Product type | Primary antibodies |
| Clonality | Monoclonal antibody |
| Isotype | IgG1 kappa |
| Activity cross reaction | Conatumumab (AMG 655) is a human monoclonal agonist antibody against human death receptor 5 |
| Species | Human |
| Labelling | None |
| Form | Purified (protein A) |
| Preservative | None |
| Storage instructions | Lyophilized powder stable for a minimum of 2 years at -20°C. Store reconstituted antibodies at +4°C. For extended periods store in aliquots at -20°C. Antibodies are guaranteed for 6 month from date of receipt. |
| Target | DR5, TRAILR2 |
| Applications | ELISA, FC, WB |
| Working dilutions | Optimal dilution should be determined by the end user. |
Write Your Own Review